Your Mounjaro price guide · October 2026
Losing Weight on GLP-1: What to Expect (October 2026)
Losing weight on GLP-1 medication means a weekly injection plus a reduced-calorie diet and more activity, and in the SURMOUNT-1 trial people on 15mg lost on average 20.9% of their body weight over 72 weeks; individual results vary. Your first 2.5mg Mounjaro pen costs £129.99 with code FIRST40 (standard price £169.99). Prices checked 10 October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
GLP-1 medicines support weight loss by making you feel fuller sooner and less hungry between meals; they work alongside diet and activity, not instead of them.
-
SURMOUNT-1 averages were 15% on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks. Individual results vary.
-
If weight loss stalls, the dose, your eating pattern and your starting point are the first things to review with your prescriber.
-
NHS access is being phased in over several years; many adults who meet the licensed criteria choose regulated private treatment.
In this guide
01 · The core answer
What losing weight on GLP-1 actually looks like
Losing weight on GLP-1 treatment means taking a once-weekly injection that reduces appetite, while you follow a reduced-calorie diet and become more active. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.1
The headline figures come from the SURMOUNT-1 trial. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2 These are trial averages and individual results vary. They do not predict your own result.
A worked example helps put the percentage in context. For someone starting at 100 kg, 20.9% is about 21 kg. Your own starting weight, dose, adherence and body will decide where you land, and some people lose less than the average while others lose more.
The pace is not instant. Many people notice reduced appetite within the first few weeks, but the bigger changes build over months.
02 · Your next step
The decisions most readers are facing
If you are deciding whether treatment is relevant, the licence matters. NICE recommends Mounjaro for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first.4 Private treatment follows the licensed criteria and starts with a free online consultation reviewed by a GPhC-registered prescriber.
If you are already on treatment and the scales have stopped moving, read our guide on GLP-1 not losing weight and the Mounjaro-specific page on why you may not be losing weight on Mounjaro. Often the answer sits in dose, eating pattern or timing rather than in the medicine itself.
If you want to understand the biology first, our explainer on why you lose weight on GLP-1 goes through the mechanism.
03 · Where to go next
A soft pathway if you are ready
If you meet the licensed criteria and want to start, the Mounjaro pen page shows live prices and the free consultation. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price. All six doses are in stock.
If you would rather read more first, our weight loss clinic hub brings together the guides in one place. There is no pressure either way: the consultation is free, there is no obligation, and unsuitable orders are refunded automatically.
Related guide: Losing too much weight on mounjaro.
Related guide: Glp1 weight loss.
04 · How GLP-1 works
How GLP-1 medicines help you lose weight
GLP-1 medicines help you lose weight mainly by changing appetite signals. They do not burn fat directly, and they do not remove the need to eat sensibly. They make a reduced-calorie diet easier to follow, and that is where the weight loss comes from.
Tirzepatide, the active ingredient in Mounjaro, is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1 In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.
That dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide, sold as Wegovy and Ozempic. Ozempic is semaglutide licensed for type 2 diabetes. It is not a UK weight-loss medicine, and the licensed weight-management options are Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4mg). If you want to see the single-action option on our site, the Wegovy pen page has the details.
Think of the medicine as turning down the background noise of food. Many people describe less preoccupation with snacks and smaller portions feeling satisfying. The effect depends on you still making choices: eating protein-rich, nutritious meals, drinking enough water and moving regularly all remain part of the plan.
Because the stomach empties more slowly, meals can feel heavier than before. That is one reason why eating more slowly and stopping when comfortably full tends to suit people on treatment. If you notice persistent discomfort, speak to your prescriber rather than pushing through.
It is also worth being clear about what the medicine is not. It is not a short-term crash method and it is not a replacement for medical oversight. It is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity.1
Understanding this mechanism can help you avoid disappointment. When you know the medicine works through appetite, you can judge your progress by how your hunger and eating behave, not only by the scales on any one day.
05 · What the trials show
What the trial results show
The main evidence for Mounjaro in weight management is the SURMOUNT-1 trial, and its results are averages across a large group. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2
These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them. A trial average does not predict your own result, and it would be a mistake to treat the top figure as a target you must hit.
The trial also reports how many people reached certain thresholds. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.2
Notice the pattern: higher doses produced larger average losses, but meaningful loss was seen at the lower doses too. That matters because not everyone moves up to the highest strength. Your prescriber balances effect against how well you tolerate each step.
When people ask how others are losing weight so fast on GLP-1, the honest answer is that the trial averages built up over 72 weeks, not days. Social media tends to show the most dramatic cases. Steady progress over many months is the more typical picture, and rapid loss is not a goal in itself.
Direct comparisons between medicines need care. SURMOUNT-5 was the first large head-to-head trial of tirzepatide and semaglutide, and results from different trials should never be set side by side as though they were. If you are weighing the two, ask your prescriber which suits your circumstances.
The takeaway is realistic optimism. The evidence supports meaningful average weight loss when the medicine is combined with diet and activity, over a long period, with individual variation. That framing protects you from both hype and unnecessary discouragement.
06 · Why weight loss stalls
Why you might not be losing weight on GLP-1
The most common reasons for slow progress are an early dose, an eating pattern that works against the medicine, or simply not having given treatment enough time. Before assuming it has failed, work through these in order. Our dedicated guides on GLP-1 not losing weight and not losing weight on Mounjaro go deeper.
You are still titrating. The lowest strength is a starting dose, and the larger average losses in the trial were seen at higher strengths. Being on an early dose means you have not yet reached the dose where the biggest effect was recorded.
Calories still add up. The medicine supports a reduced-calorie diet; it does not cancel out the calories you eat. Liquid calories, grazing, alcohol and energy-dense snacks can quietly fill the gap that reduced appetite creates. Keeping a simple food log for a short spell often shows where the energy is going.
Activity has dropped. Some people feel tired in the early weeks and move less. Treatment is meant to be used alongside increased physical activity, so gentle, regular movement matters, particularly walking and resistance work that you can sustain.
Sleep, stress and other medicines. Poor sleep and high stress can affect appetite and choices. Some other medicines can affect weight too. Raise this with your prescriber rather than changing anything yourself.
Weight is not a straight line. Daily fluctuations from fluid, digestion and hormones can mask real progress. Compare trends over weeks, and consider other markers such as how clothes fit, how hungry you feel and how much energy you have.
Individual variation. Trial results are averages, and individual results vary. Some people respond more slowly than others, and that is not a failure of willpower.
Any change should come from your prescriber. Our ongoing monthly reviews exist precisely so that stalls can be looked at properly, with dose, side effects and habits considered together.
07 · Hunger, food and meal plans
Hunger, food choices and meal planning
If you feel hungry on GLP-1 treatment, that does not necessarily mean the medicine is not working. Appetite reduction varies between people and between days. In practice, most people feel fuller sooner and less hungry between meals, but it is not identical for everyone.1
The medicine slows stomach emptying, so very rich, greasy or large meals may sit uncomfortably for some people. Smaller, regular, balanced meals tend to feel easier.
A practical meal plan usually has these features: a source of protein at each meal, plenty of vegetables, wholegrain or high-fibre carbohydrates in sensible portions, and fewer sugary drinks and ultra-processed snacks. This is general healthy-eating guidance rather than a prescription, and a registered dietitian can tailor it to your needs, particularly if you have other health conditions.
Do's usually include eating slowly, stopping when comfortably full, staying hydrated, keeping up gentle activity, attending reviews and reporting new symptoms. Don'ts usually include skipping meals entirely, relying on the medicine to excuse a poor diet, and changing your dose yourself.
If you feel persistently very hungry, think about timing, sleep, protein and whether you are eating enough to be satisfied across the day. Share the pattern with your prescriber, who can consider whether your dose and plan are right.
For side effects such as nausea or digestive upset, the patient information leaflet and your prescriber are the right sources. You can also report suspected side effects through the Yellow Card scheme. Do not treat online meal-plan lists as medical advice.
If you track food, mood and symptoms, our free GLPTrackr companion app is designed for following a GLP-1 journey, and it gives you something concrete to discuss at review appointments.
08 · NHS and private
NHS and private access to GLP-1 treatment
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46
Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. If you think you may qualify for NHS care, speak to your GP first. NHS access to Wegovy runs through specialist weight-management services, so ask your GP.
Choosing private treatment is a personal decision, and it should be through a registered pharmacy. We are a GPhC-registered UK online pharmacy, registration 9012878, and you can check us on the GPhC public register. Our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens.
The journey is straightforward. You complete a free online consultation, which is a short health questionnaire with no charge and no obligation. A GPhC-registered prescriber reviews it. Payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
Approved orders are dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm. Delivery is free, next-day, tracked and temperature-controlled, and Saturday delivery is £14.99.
Whichever route you take, the medicine is used alongside a reduced-calorie diet and increased physical activity. The route affects who prescribes and how you pay, not what the medicine does.
Be cautious of anyone offering to supply without a consultation or prescription. Counterfeit medicines are a known risk, which is why regulated supply and the MHRA counterfeit alerts matter.7
09 · Planning the cost
Planning the cost of treatment
Because treatment is long term, it helps to plan costs across months rather than looking at a single pen. Everything here is at standard prices before discounts, and live figures are shown on the Mounjaro product page.
If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A new customer's first order is £40 less with code FIRST40, and every later order is £25 less (code DOSE25).
After titration, the monthly cost depends on the dose you settle at. Each pen lasts four weeks. At standard prices a pen costs £218.99 at 5mg, £279.99 at 7.5mg, £290.99 at 10mg, £319.99 at 12.5mg and £329.99 at 15mg. Per week, that works out at £54.75 at 5mg and £82.50 at 15mg.
A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, before discounts. Those totals are an upper planning guide: a new customer's first order is £40 less, and every later order is £25 less.
Across the UK pharmacies we track, Mounjaro pens range from £143.96 to £339.00 per month depending on dose and provider, checked 10 October 2026. The gap between providers for the same dose can be as small as £27 or as large as £41, so comparing is worthwhile.
The price shown is the price paid: the consultation is free and there are no hidden fees. We accept Visa and Mastercard, Klarna and pay-monthly options, and there are no subscriptions, so repeat orders re-check suitability and nothing ships automatically.
10 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
11 · Getting started safely
Getting started safely and getting the most from treatment
To get the most from treatment, start through a regulated route, follow the dose plan and treat diet and activity as part of the medicine, not an optional extra. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.1
Begin with an honest consultation. Answer the health questions fully, because the prescriber needs the complete picture to judge whether treatment is suitable. Our consultation is a short health questionnaire, free, with no obligation. It is reviewed by a GPhC-registered prescriber, not a scoring script.
Build habits during the early weeks, when the dose is low and the medicine is still settling in. Establish regular meals, a walking routine and a sleep pattern you can keep. Those habits are what carry you through when the dose is higher and, later, if treatment ever changes.
Track what you can. A food log, a weekly weigh-in and notes on appetite and side effects give you and your prescriber real information. The free GLPTrackr companion app, on iOS and Android, is built for this.
Choose your supplier carefully. Check that a pharmacy is on the GPhC register, and avoid sellers offering to supply without a consultation or prescription. Genuine pens come with needles, a sharps bin and injection guidance, which we include with every order.
Be realistic about timelines. Early weeks are about adjusting, not judging success.
If you are comparing options or want to understand the diet side first, the weight loss clinic hub is a good next stop. When you are ready, the Mounjaro pen page lets you begin the free consultation at your own pace.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamHow to maximise weight loss on GLP-1?
How quickly do you lose weight on GLP-1 medicines?
Why am I not losing weight on GLP-1?
How are people losing weight so fast on GLP-1?
What do I wish I knew before starting GLP-1?
What foods should you avoid while taking GLP-1?
What are the do's and don'ts when taking GLP-1?
Why am I so hungry on GLP-1?
What should I eat in my meal plan when taking GLP-1?
Is there a weight watcher GLP-1 option?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 7 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med 2025
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


